The Oregonian, November 19, 2010
Two years after receiving a $100 million gift from Phil and Penny Knight to support cancer care and research, Oregon Health & Science University has settled on a strategy to become a regional powerhouse in "personalized medicine" for the disease.
The three-prong plan includes a recruiting drive for researchers, the launch of a commercial DNA testing lab and the expansion of the university's cancer tissue bank into a unique and potentially profitable resource for researchers and drug companies.
